explore -WSS

explore

author：comprehensive 2025-10-01 14:59:32 - browse：2

Andrea Coravos, managing director at ICON, speaks at the STAT Breakthrough Summit West in San Francisco Thursday as Ida Sim, chief research informatics officer at UCSF, looks on. Sarah Gonzalez for STAT

Just because the Food and Drug Administration has given the Apple Watch and other wearable devices the OK to market the health benefits of their tracking and algorithms doesn’t mean that the data they generate are useful for either patients or their doctors, experts said Thursday at the STAT Breakthrough Summit West in San Francisco.

“Yesterday, I saw a patient with type 2 diabetes who has a continuous glucose monitor, and so she’s been tracking her blood sugar every five minutes,” said Ida Sim, a primary care physician and chief research informatics officer at the University of California, San Francisco. “[I] sat with her for almost an hour yesterday. I couldn’t get to her CGM data — she had it on her phone, but the report goes into a website that I didn’t have the login to, and it hadn’t been downloaded into my electronic medical record. So all this tracking data, I didn’t have it.”

Not only do clinicians not have the ability to access data that their patients want to use to guide their care, but primary care doctors often don’t know how to interpret that firehose of data, said Sim. She asked some of her endocrinology research colleagues how they use that data and they explained the calculations needed to create biomarker metrics from them. That made the data largely useless to her as a doctor, and it was frustrating.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： UnitedHealth’s Optum accused of antitrust violations in California

WSS

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Childbirth

Despite FDA concern, risk that CAR

Startling documents reveal new facets of Sacklers' opioid empire

Latest bird flu infection made farmworker sicker than earlier cases

Average age of first period drops to 11.9 years, study shows

knowledge

explore

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Wikipedia

BioMarin wins approval for gene therapy to treat hemophilia A

David Sabatini, ex

Drug repurposing or repositioning? The language matters

Addiction doctors spar with methadone clinics over legislation

Hepatitis C has a cure — but many Americans still lack access to it

Addiction doctors spar with methadone clinics over legislation

Peter Hotez and the public health issue of online harassment

U.K. Biobank has 500,000 peoples' genome sequences available

State Dept. review finds Biden bears some blame for Afghanistan failures

Takeda, Janssen join wearable maker to measure scratching

Wikipedia

U.K. Biobank has 500,000 peoples' genome sequences available

Will the market for weight loss drugs really reach $100 billion?

What will save rural psychiatry services? Higher Medicaid payments

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Takeda, Janssen join wearable maker to measure scratching

What will save rural psychiatry services? Higher Medicaid payments

explore

focus

knowledge

knowledge